1. Home
  2. MDGL vs OTEX Comparison

MDGL vs OTEX Comparison

Compare MDGL & OTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • OTEX
  • Stock Information
  • Founded
  • MDGL 2011
  • OTEX 1991
  • Country
  • MDGL United States
  • OTEX Canada
  • Employees
  • MDGL N/A
  • OTEX N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • OTEX EDP Services
  • Sector
  • MDGL Health Care
  • OTEX Technology
  • Exchange
  • MDGL Nasdaq
  • OTEX Nasdaq
  • Market Cap
  • MDGL 9.6B
  • OTEX 9.9B
  • IPO Year
  • MDGL N/A
  • OTEX 1998
  • Fundamental
  • Price
  • MDGL $439.54
  • OTEX $39.16
  • Analyst Decision
  • MDGL Strong Buy
  • OTEX Hold
  • Analyst Count
  • MDGL 12
  • OTEX 11
  • Target Price
  • MDGL $521.09
  • OTEX $35.27
  • AVG Volume (30 Days)
  • MDGL 275.2K
  • OTEX 953.4K
  • Earning Date
  • MDGL 10-28-2025
  • OTEX 11-05-2025
  • Dividend Yield
  • MDGL N/A
  • OTEX 2.82%
  • EPS Growth
  • MDGL N/A
  • OTEX N/A
  • EPS
  • MDGL N/A
  • OTEX 1.65
  • Revenue
  • MDGL $515,547,000.00
  • OTEX $5,168,405,000.00
  • Revenue This Year
  • MDGL $394.08
  • OTEX $3.15
  • Revenue Next Year
  • MDGL $61.80
  • OTEX $1.73
  • P/E Ratio
  • MDGL N/A
  • OTEX $23.65
  • Revenue Growth
  • MDGL 3421.98
  • OTEX N/A
  • 52 Week Low
  • MDGL $200.63
  • OTEX $22.79
  • 52 Week High
  • MDGL $463.63
  • OTEX $39.90
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 56.11
  • OTEX 63.71
  • Support Level
  • MDGL $416.29
  • OTEX $38.50
  • Resistance Level
  • MDGL $451.02
  • OTEX $39.90
  • Average True Range (ATR)
  • MDGL 16.36
  • OTEX 0.81
  • MACD
  • MDGL -2.24
  • OTEX -0.15
  • Stochastic Oscillator
  • MDGL 49.11
  • OTEX 75.41

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About OTEX Open Text Corporation

Open Text Corp is engaged in the design, development, marketing, and sale of Information Management software and solutions. Its software allows clients to archive, aggregate, retrieve, and search unstructured information (such as documents, e-mail, and presentations). Its platform and services provide secure and scalable solutions for enterprises, SMBs, governments, and consumers around the world. The company's solutions are marketed and delivered on the OpenText Cloud Platform, which is a comprehensive Information Management platform consisting of six business clouds; Content Cloud, Cybersecurity Cloud, Application Automation Cloud, Business Network Cloud, IT Operations Management Cloud, and Analytics Cloud. Geographically, it derives maximum revenue from the United States.

Share on Social Networks: